NOV 03, 2016 6:00 AM PDT

Automation and core-laboratory: experience of a large European academic hospital

Speaker
  • Professor, Head of the Department of Clinical Biochemistry, Cliniques Universitaires Saint Luc
    Biography
      Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc. He is also member of the research unit on Endocrinology Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is member of the division on Emerging Technology of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Pr. D. Gruson is also Fellow of the European Society of Cardiology.

    Abstract

    Core or central laboratory are facing several challenges. First, the management and operations of a successful modern laboratory is a real complex exercise, with multiple pre- and post-analytic (also know as peri-analytical) steps. Second, today, pressure from a hard economical climate, together with consolidation and merging of laboratories, is resulting in a far more competitive environment between laboratories. Third, the operational efficiency should be taken to a more advantageous cost base without compromising growth and quality. 

    Automation is therefore providing several advantages such as the improvement of specimen processing and laboratory workflows, the reduction and stabilisation of the turnaround time of analysis (TAT), the upgrade of global quality procedures, the enhancement of laboratory productivity as well as competiveness and finally by reducing human errors which will ultimately lead to improvement of patient safety and care. 

    However, the automation of a laboratory is far from an easy task and laboratory managers have deal with several steps such as the selection of pre- and post- analytical modules, potential sample conveyors systems, the choice of analytical units, the revision of the laboratory processes, the project management as well as the implementation and change management phases and the selection of partner(s) from in vitro diagnostic industry. It is also really important to point out that the efficiency of an automation solution will be highly dependent of the informatics and middleware platforms performances.

    As the laboratories are more and more consolidated and the core-laboratories are acting as multi-disciplinary (chemistry, immunology, virology, haematology, haemostasis…) platforms and have to deal with the production and accreditation requirements, we have to consider a matrix approach for the selection process of the assays boarding on an automation solution.

    We have therefore run a multidisciplinary project management, integrating both clinical and operational constraints, to define needs, criteria of choice and finally implement an automation system. 
     


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    AUG 18, 2020 10:00 AM PDT
    C.E. CREDITS
    AUG 18, 2020 10:00 AM PDT
    DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
    Loading Comments...
    Show Resources